AMPICILLIN AND BETA-LACTAMASE INHIBITOR

TAILORED-PROM: TAILORED therapeutic regime in patients with preterm Premature Rupture Of Membranes to prolong pregnancy, improve maternal and neonatal outcomes, and reduce antibiotic burden

A Phase 3 prospective, randomized, multicenter, active-controlled study to evaluate the efficacy and safety of BV100 plus low-dose polymyxin B compared with colistin plus high-dose ampicillin/sulbactam in the treatment of adult patients with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol - A multi-national pharmacokinetic/pharmacodynamic cohort study to determine whether contemporary antibiotic dosing for critically ill patients achieves therapeutic exposures.